Highbridge Capital Management

HCM is a global alternative investment management firm launched in 1992. Since its inception, the company has developed a diversified investment platform that includes hedge funds, traditional investment management products and debt and private equity investments with longer-term holding periods. With over 300 employees, including almost 100 investment professionals, HCM manages approximately $21 billion of capital for some of the world's most prominent institutional investors, public and corporate pension funds, endowments, foundations and family offices.

Highbridge Capital Management, established in 1992 and headquartered in New York, New York, United States, North America., specializes in Private Equity, Late Stage Venture, Early Stage Venture investments across Biotechnology, Health Care, Pharmaceutical, Medical, Oncology, Financial Services, Angel Investment, Banking, Venture Capital, Finance. The organization boasts a portfolio of 28 investments, with an average round size of $65.0M and 19 successful exits. Their recent investments include EUSA Pharma, Bank of America Securities, HBK Capital Management, OrbiMed, Iroquois Capital. The highest investment round they participated in was $74.8B. Among their most notable exits are EUSA Pharma and Bank of America Securities. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.